University of California San Francisco
Give to UCSFIn medical school, Nathan Lo thought we could do more to help the 750 million people around the world with or at risk of getting schistosomiasis. This week, he helped World Health Organization rewrite guidelines to treat everyone in affected communities.
A new fast-track review for UCSF gene therapy could help more kids with deadly Artemis-SCID disease get life-saving treatment sooner.
Using data from over 100,000 malignant and non-malignant cells from 15 human brain metastases, UCSF researchers have revealed two functional archetypes of metastatic cells across 7 different types of brain tumors, each containing both immune and non-immune cell types.
Three UC San Francisco researchers have been selected as 2021 fellows of the American Association for the Advancement of Science (AAAS), the world's largest multidisciplinary scientific society and a leading publisher of cutting-edge research through its Science family of journals. They are among 564 newly elected fellows announced Jan. 26.
Microbiologist Joseph Bondy-Denomy, PhD, has been selected as the 2022 William K. Bowes Jr. Biomedical Investigator for his groundbreaking discovery of a secret weapon deployed by viruses in their ancient battle against bacteria.
Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.
In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.
UCSF researchers found that cancers from different parts of the body are immunologically similar to one another. They described 12 classes of "immune archetypes" to classify cancer tumors, which can provide unique strategies for enhancing patients’ choice of cancer immunotherapies.
A new study led by scientists at UCSF's Quantitative Biosciences Institute and University College London found that the Alpha variant of SARS-CoV-2 ramped up production of a protein that it uses to stifle infected cells’ immune-stimulating signals, helping it evade immune detection and accelerate its transmission.
There is some information that is known about the variant and other information that sti
A concerted research effort gave UCSF scientists early insight into long COVID. It also showed patients that they weren’t in the fight alone.
Monica Gandhi, MD, MPH, an infectious disease expert and professor of medicine, has been an ardent voice for science during the coronavirus pandemic.
Since the early months of the pandemic, physicians throughout UCSF have pitched in to help support hundreds of long COVID patients.